Get the Stockscreener App
61.44
0.95%
0.58
After Hours:
61.44
Prestige Consumer Healthcare Inc stock is traded at $61.44, with a volume of 325.81K.
It is up +0.95% in the last 24 hours and up +1.54% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$60.86
Open:
$60.9
24h Volume:
325.81K
Relative Volume:
0.72
Market Cap:
$2.95B
Revenue:
$1.12B
Net Income/Loss:
$213.00M
P/E Ratio:
14.42
EPS:
4.2622
Net Cash Flow:
$267.84M
1W Performance:
+1.02%
1M Performance:
+1.54%
6M Performance:
-27.84%
1Y Performance:
-26.49%
1-Day Range:
$60.55
$61.57
1-Week Range:
$59.52
$62.14
52-Week Range:
$57.25
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
61.44 | 2.93B | 1.12B | 213.00M | 267.84M | 4.2622 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Upgrade | Sidoti | Neutral → Buy |
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Investors in Prestige Consumer Healthcare (NYSE:PBH) have seen notable returns of 70% over the past five years - simplywall.st
Responsive Playbooks and the PBH Inflection - news.stocktradersdaily.com
Here’s why analysts are positive on Prestige Consumer Healthcare Inc. (PBH) - MSN
Here’s Why Analysts Are Positive On Prestige Consumer Healthcare Inc. (PBH) - Insider Monkey
Implied Volatility Surging for Prestige Consumer Stock Options - Yahoo Finance
Brandes Small Cap Value Fund Initiated a Position in Prestige Consumer Healthcare (PBH) on a Dip - Insider Monkey
What drives Prestige Consumer Healthcare Inc stock priceLow Beta Stocks & High Yield Portfolio Growth - earlytimes.in
Wall Street Analysts Believe Prestige Consumer Healthcare (PBH) Could Rally 26.06%: Here's is How to Trade - Finviz
Prestige Consumer Healthcare Earnings Notes - Trefis
Will Prestige Consumer Healthcare Inc. (PBV) stock deliver stable dividendsEntry Point & Safe Entry Momentum Tips - Newser
Can Prestige Consumer Healthcare Inc. (PBV) stock sustain revenue momentumJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
What market sentiment indicators show for Prestige Consumer Healthcare Inc. stockJuly 2025 Outlook & Safe Capital Preservation Plans - Newser
Why retail traders accumulate Prestige Consumer Healthcare Inc. stockJuly 2025 Sentiment & Stock Market Timing Techniques - Newser
Is Prestige Consumer Healthcare Inc. stock prepared for digital transitionJuly 2025 Pullbacks & Low Drawdown Momentum Ideas - Newser
Will Prestige Consumer Healthcare Inc. (PBV) stock benefit from sector leadershipWeekly Risk Summary & Smart Allocation Stock Reports - Newser
Franklin Resources Inc. Increases Position in Prestige Consumer Healthcare Inc. $PBH - Defense World
Who are in the management team of Prestige Consumer Healthcare, Inc.? - Markets Mojo
Insider Selling: Prestige Consumer Healthcare (NYSE:PBH) VP Sells 281 Shares of Stock - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) VP Jeffrey Zerillo Sells 719 Shares - MarketBeat
Fecal Incontinence Therapeutics Market Rapied Growth in GCC - openPR.com
Fisher Asset Management LLC Lowers Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Senior VP Operations Sells Shares - TradingView
VP Zerillo Sells 1,000 ($60K) Of Prestige Consumer Healthcare Inc [PBH] - TradingView
Prestige Consumer Healthcare (PBH) officer reports stock sales in Form 4 filing - Stock Titan
Pullback Watch: Is Prestige Consumer Healthcare Inc stock a top momentum playQuarterly Profit Summary & Low Risk Entry Point Guides - BỘ NỘI VỤ
Edgestream Partners L.P. Makes New Investment in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. $PBH Shares Acquired by Rhumbline Advisers - MarketBeat
How analysts revise price targets for Prestige Consumer Healthcare Inc. (PBV) stockJuly 2025 Setups & Low Risk Profit Maximizing Plans - Newser
Aug Reactions: Why global investors buy Prestige Consumer Healthcare Inc. (PBV) stock2025 Institutional Moves & Low Risk Profit Maximizing Plans - BỘ NỘI VỤ
VP Zerillo Files To Sell 281 Of Prestige Consumer Healthcare Inc [PBH] - TradingView
PBH (NYSE: PBH) insider files Rule 144 to sell 281 common shares - Stock Titan
Understanding the Setup: (PBH) and Scalable Risk - news.stocktradersdaily.com
Wall Street Recap: What makes Prestige Consumer Healthcare Inc. (PBV) stock appealing to growth investors2025 Year in Review & Capital Efficient Trade Techniques - BỘ NỘI VỤ
PBH (NYSE: PBH) investor files Form 144 to sell 719 common shares - Stock Titan
Zacks Research Analysts Raise Earnings Estimates for PBH - Defense World
Sell Alert: John E Byom Cashes Out $178K In Prestige Consumer Stock - Benzinga
Insider Sell: John Byom Sells 3,000 Shares of Prestige Consumer Healthcare Inc (PBH) - GuruFocus
Is Prestige Consumer Healthcare Inc. stock a top momentum play2025 Market Overview & Short-Term Trading Alerts - moha.gov.vn
Why Prestige Consumer Healthcare Inc. stock remains top rated2025 Short Interest & Accurate Entry and Exit Point Alerts - moha.gov.vn
What analysts say about Prestige Consumer Healthcare Inc stockHigh Dividend Yield Stocks & Low Cost Trading Ideas - earlytimes.in
How Economic Recovery Impacts Amin Tannery Limited Stock ProspectsFinancial Sector Performance & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Dir Byom Sells 3,000 ($178.1K) Of Prestige Consumer Healthcare Inc [PBH] - TradingView
[Form 4] Prestige Consumer Healthcare Inc. Insider Trading Activity - Stock Titan
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly - 富途牛牛
Risk-to-Price Commentary: Prestige Brands Inc. - S&P Global
[144] Prestige Consumer Healthcare Inc. SEC Filing - Stock Titan
Dir Byom Files To Sell 3,000 Of Prestige Consumer Healthcare Inc [PBH] - TradingView
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Contrasting Prestige Consumer Healthcare (NYSE:PBH) and Cresco Labs (OTCMKTS:CRLBF) - Defense World
Prestige Consumer Healthcare Beats Q2 Expectations and Raises EPS Guidance - MSN
Magnetar Financial LLC Acquires 38,648 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):